As high-throughput sequencing and immune profiling technologies advance, BTLA expression patterns have been found to correlate not only with immune cell dysfunction but also with tumor aggressiveness, metastatic potential, and resistance to therapy [6,63,81]. This evidence concerns the gene BTLA and neoplasm.